share_log

SVB Securities Initiates Coverage On CureVac With Outperform Rating, Announces Price Target of $13

SVB Securities Initiates Coverage On CureVac With Outperform Rating, Announces Price Target of $13

SVB Securities以跑贏大盤的評級啓動對CureVac的報道,宣佈目標股價爲13美元
Benzinga ·  2023/06/08 08:45

SVB Securities analyst Mani Foroohar initiates coverage on CureVac (NASDAQ:CVAC) with a Outperform rating and announces Price Target of $13.

SVB證券分析師瑪尼·福魯哈爾以跑贏大盤的評級啓動了對CureVac(納斯達克股票代碼:CVAC)的報道,並宣佈目標股價爲13美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論